This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.NMDA receptors play a key role in many functions of the CNS such as synaptic plasticity and the initiation of cell death in neuropathological conditions. Years ago, our laboratory first identified 4 pharmacologically-distinct subtypes of NMDA receptors. More recently, using subtype-selective antagonists that we developed, we were the first to show that the fundamental processes of long-term potentiation and long-term depression were mediated by different subtypes of NMDA receptors (J. Neursci. 20:RC81, 1-6, (2000)) and that two pharmacologically-distinct NMDA receptor-mediated synaptic components can be identified the same synaptic pathway (J. Physiol. 558.2: 451-463 (2004)). We have now begun identifying signal transduction systems that are specifically associated with individual NMDA receptor subunits. As part of this project, we have generated 5 constructs coding for intracellular portions of one of the NMDA receptor subunits each of which contain several protein-protein interaction domains. Using a pull-down of brain lysate followed by a silver stain, we find that several discrete proteins are recognized by each of our constructs. With the UCSF mass spectrometry collaboration we have now identified several signaling molecules that can account for many of the actions of NMDA receptor activation such as synaptic plasticity and also to excitotoxic cell death.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR001614-26
Application #
7724218
Study Section
Special Emphasis Panel (ZRG1-BCMB-M (40))
Project Start
2008-06-01
Project End
2009-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
26
Fiscal Year
2008
Total Cost
$8,473
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
MacRae, Andrew J; Mayerle, Megan; Hrabeta-Robinson, Eva et al. (2018) Prp8 positioning of U5 snRNA is linked to 5' splice site recognition. RNA 24:769-777
Katsuno, Yoko; Qin, Jian; Oses-Prieto, Juan et al. (2018) Arginine methylation of SMAD7 by PRMT1 in TGF-?-induced epithelial-mesenchymal transition and epithelial stem-cell generation. J Biol Chem 293:13059-13072
Sahoo, Pabitra K; Smith, Deanna S; Perrone-Bizzozero, Nora et al. (2018) Axonal mRNA transport and translation at a glance. J Cell Sci 131:
Tran, Vy M; Wade, Anna; McKinney, Andrew et al. (2017) Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion. Mol Cancer Res 15:1623-1633
Liu, Tzu-Yu; Huang, Hector H; Wheeler, Diamond et al. (2017) Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics. Cell Syst 4:636-644.e9
Kintzer, Alexander F; Stroud, Robert M (2016) Structure, inhibition and regulation of two-pore channel TPC1 from Arabidopsis thaliana. Nature 531:258-62
Bikle, Daniel D (2016) Extraskeletal actions of vitamin D. Ann N Y Acad Sci 1376:29-52
Twiss, Jeffery L; Fainzilber, Mike (2016) Neuroproteomics: How Many Angels can be Identified in an Extract from the Head of a Pin? Mol Cell Proteomics 15:341-3
Cil, Onur; Phuan, Puay-Wah; Lee, Sujin et al. (2016) CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation. Cell Mol Gastroenterol Hepatol 2:317-327
Posch, Christian; Sanlorenzo, Martina; Vujic, Igor et al. (2016) Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2? Kinase Levels in NRAS(Q61) Mutant Cells. J Invest Dermatol 136:2041-2048

Showing the most recent 10 out of 630 publications